Skip to main content

Beneficial ownership — 13D / 13G

87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Ian McDonald DRUG Bright Minds Biosciences Inc. 13D/A 30.56% 2y
Erich Spangenberg MDAI Spectral AI, Inc. 13D/A 29.1% 2y
Cowen Financial Products LLC STOK Stoke Therapeutics, Inc. 13G 5.77% 2y
Landon Lovig AVNI Arvana Inc 13G 5.56% 2y
Ian McDonald DRUG Bright Minds Biosciences Inc. 13D/A 8.88% 2y
PERCEPTIVE ADVISORS LLC NVNO enVVeno Medical Corp 13G/A 9.9% 2y
Point72 Asset Management, L.P. VTYX Ventyx Biosciences, Inc. Common Stock 13G 5.1% 2y
Point72 Asset Management, L.P. CRBU Caribou Biosciences, Inc. 13G 5% 2y
David A. Ladensohn SYM Symbotic Inc. 13D/A 66% 2y
Janet L. Cohen SYM Symbotic Inc. 13D/A 62.6% 2y
Abdiel Qualified Master Fund, LP APPN Appian Corp 13D/A 14% 2y
Richard B. Cohen SYM Symbotic Inc. 13D/A 68.1% 2y
Camac Partners, LLC ABCP AmBase Corp 13D/A 8.7% 2y
Kash Sheikh EVE EVe Mobility Acquisition Corp 13D/A 19.2% 2y
ADAR1 Partners, LP TECX Tectonic Therapeutic, Inc. 13G 7.4% 2y
Deep Track Capital, LP ENGN enGene Therapeutics Inc. 13G 5.21% 2y
L1 Capital Global Opportunities Master Fund, Ltd. SBFM Sunshine Biopharma Inc. 13G 5.3% 2y
S.H.N. Financial Investments Ltd. BIOL Biolase, Inc. 13G 9.9% 2y
ADAGE CAPITAL PARTNERS GP, L.L.C. BBOT BridgeBio Oncology Therapeutics, Inc. 13G 7.4% 2y
Yakira Capital Management, Inc. BITE Bite Acquisition Corp. 13G/A 0.75% 2y
Brian R. Mariotti FNKO Funko, Inc. 13G/A 1.18% 2y
The AES Corporation FLNC Fluence Energy, Inc. 13G/A 29% 2y
Hilton Hiller Schlosberg MNST Monster Beverage Corp 13D/A 7.8% 2y
EcoR1 Capital, LLC ZYME Zymeworks Inc. 13D 19.99% 2y
ASP BB HOLDINGS LLC BLBD Blue Bird Corp 13D/A 0% 2y
Bryan G. Glazer Irrevocable Exempt Trust MANU Manchester United plc 13D/A 21.8% 2y
VITO GARFI SQFT Presidio Property Trust, Inc. 13D/A 4.1% 2y
Kevin Glazer Irrevocable Exempt Family Trust MANU Manchester United plc 13D/A 17.1% 2y
Voss Capital, LP GFF Griffon Corp 13D/A 2.6% 2y
James N. Topper KALV KalVista Pharmaceuticals, Inc. 13D/A 8.9% 2y
Beach Point Capital Management LP DBD DIEBOLD NIXDORF, Inc 13D/A 7.9% 2y
Avram Glazer Irrevocable Exempt Trust MANU Manchester United plc 13D/A 18% 2y
Darcie S. Glazer Irrevocable Exempt Trust MANU Manchester United plc 13D/A 23.5% 2y
First City Investment Group, LLC MDV Modiv Industrial, Inc. 13G 14.7% 2y
COWEN AND COMPANY, LLC CURR Currenc Group Inc. 13G/A 8% 2y
180 Degree Capital Corp. SCOR Comscore, Inc. 13D/A 7.2% 2y
Joel M. Glazer Irrevocable Exempt Trust MANU Manchester United plc 13D/A 25.7% 2y
BIOTECHNOLOGY VALUE FUND L P ENGN enGene Therapeutics Inc. 13G/A 7.2% 2y
Group of Trophy, LLC MDV Modiv Industrial, Inc. 13G/A 0% 2y
Edward S. Glazer Irrevocable Exempt Trust MANU Manchester United plc 13D/A 15.9% 2y
ARCH Venture Fund XII, L.P. PRME Prime Medicine, Inc. 13D 12.9% 2y
Kirti Desai TVGN Tevogen Inc. 13D 5.9% 2y
James C. Flores SOC Sable Offshore Corp. 13D 25.5% 2y
Ryan H. Saadi TVGN Tevogen Inc. 13D 71.9% 2y
Davidson Kempner Capital Management LP TPHS Trinity Place Holdings Inc. 13D 40.6% 2y
Christopher B. Sarofim SOC Sable Offshore Corp. 13D 11.4% 2y
ADAR1 Partners, LP MACK Merrimack Pharmaceuticals, Inc. 13G 6.3% 2y
Michael P. Rubin KYTX Kyverna Therapeutics, Inc. 13G 7.6% 2y
D. E. Shaw & Co., L.P. PLCE Childrens Place, Inc. 13G/A 7.3% 2y
DANIEL TOLHURST ABTC American Bitcoin Corp. 13G 8.53% 2y